Characteristic LMWH (Enoxaparin) Oral Anti-coagulant (Dabigatranetexalate/Apixaban)
Treated patients 50 50
Age 60(+/-)11 60(+/-)10
female sex 32 34
weight kg 70(+/-)20 70(+/-)20
body mass index 27(+/-)5 27(+/-)5
Creatinine clearance 100(+/-)25 100(+/-)25
RACE – Asian 50(100%) 50(100%)
History of DVT NIL NIL
TYPE OF ANAESTHESIA
General 10 7
Reginal 36 38
General &Reginal 4 5
Duration of Hosiptal stay 15(15-28)days 15(15-20)days
Duration of treatment 15 days 15 days
Duration of Study including follow up 15 days 15 days
Table 1: Characteristics of Study.